Chronic Thromboembolic Pulmonary Hypertension: the Bedside.

Current Cardiology Reports
Yuri MatusovSudarshan Rajagopal


Chronic thromboembolic pulmonary hypertension (CTEPH), included in group 4 PH, is an uncommon complication of acute pulmonary embolism (PE), in which emboli in the pulmonary vasculature do not resolve but rather form into an organized scar-like obstruction which can result in right ventricular (RV) failure. Here we provide an overview of current diagnosis and management of CTEPH. CTEPH management is complex with treatments that range from surgery, percutaneous interventions, to medical therapies. Current CTEPH medical therapies have largely been repurposed from pulmonary arterial hypertension (PAH). The diagnosis of CTEPH can be challenging, requiring a multimodality approach to differentiate from disease mimics. While these treatments improve symptoms, they may not reverse the underlying pathology of CTEPH.


Apr 1, 1985·AJR. American Journal of Roentgenology·W W WoodruffJ T Chen
Apr 8, 1998·AJR. American Journal of Roentgenology·M A KingC J Bergin
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·C J ArchibaldK M Moser
Mar 8, 2000·The European Respiratory Journal·M WolfG Simonneau
Aug 19, 2000·The New England Journal of Medicine·P A KyrleS Eichinger
Aug 2, 2002·The New England Journal of Medicine·Horst OlschewskiUNKNOWN Aerosolized Iloprost Randomized Study Group
Nov 5, 2002·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Stefano GhioLuigi Tavazzi
Sep 6, 2003·Thrombosis and Haemostasis·Diana BondermanIrene M Lang
May 28, 2004·The New England Journal of Medicine·Vittorio PengoUNKNOWN Thromboembolic Pulmonary Hypertension Study Group
Oct 26, 2005·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Thorsten KrammEckhard Mayer
Apr 26, 2006·Circulation·Marius M HoeperLewis J Rubin
Sep 12, 2006·Proceedings of the American Thoracic Society·Irene Lang, Kim Kerr
Sep 12, 2006·Proceedings of the American Thoracic Society·Nazzareno Galiè, Nick H S Kim
Sep 12, 2006·Proceedings of the American Thoracic Society·Richard Coulden
Nov 28, 2006·The Annals of Thoracic Surgery·Patricia A ThistlethwaiteStuart W Jamieson
Jan 3, 2007·The Journal of Thoracic and Cardiovascular Surgery·Andrea M D'ArminiMario Viganò
Feb 27, 2007·Journal of Thrombosis and Haemostasis : JTH·N Skoro-SajerI M Lang
Apr 4, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Ségolène CabrolOlivier Sitbon
May 4, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nina TunariuAdil Al-Nahhas
Feb 23, 2008·American Journal of Respiratory and Critical Care Medicine·Robin CondliffeJoanna Pepke-Zaba
Sep 19, 2008·The European Respiratory Journal·D BondermanI M Lang
Sep 23, 2008·The Annals of Thoracic Surgery·Marius BermanDavid P Jenkins
Dec 20, 2008·Journal of the American College of Cardiology·Xavier JaïsUNKNOWN Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group
Mar 28, 2009·The European Respiratory Journal·G KovacsH Olschewski
Jan 28, 2011·The New England Journal of Medicine·Gregory Piazza, Samuel Z Goldhaber
Feb 19, 2011·American Journal of Respiratory and Critical Care Medicine·Peter FedulloWilliam R Auger
Feb 22, 2011·The Journal of Thoracic and Cardiovascular Surgery·Eckhard MayerPhilippe Dartevelle
May 11, 2011·Archives of Internal Medicine·Renda Soylemez WienerSteven Woloshin
Aug 20, 2011·Thrombosis Research·Thomas M BerghausMartin Schwaiblmair
Dec 22, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Koichiro SugimuraHiroaki Shimokawa
Mar 2, 2012·European Respiratory Review : an Official Journal of the European Respiratory Society·D JenkinsM Madani

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.